Grab your favorite coffee. This is where you’ll find all the substance you require, and more.

Cognivia-Narrow-Hero-1
cognivia signal launch
News

Introducing Cognivia Signal: Early-Warning Behavioral Risk Intelligence for Clinical Trials

Cognivia launches the world’s first early-warning behavioral risk intelligence dashboard—Cognivia Signal—empowering clinical teams to see what’s coming before it happens. Mont-Saint-Guibert, Belgium – October 9, 2025 – Cognivia,…

Read More
Insights

Regulatory Guidelines for the Use of Baseline Covariates to Increase Clinical Trial Study Power

Clinical trials data analyses can employ baseline covariates to control for factors that may impact measurement of outcomes – particularly to describe individual patient characteristics that may…

Read More
Insights

Does the placebo response need to be considered in clinical trials for COVID-19 vaccines and treatments?

The search for drugs to treat and prevent SARS-CoV-2 infection is ongoing, with more than 1200 drugs in the pipeline and more 3,200 clinical trials planned or…

Read More
Insights

Frequently asked questions about COV-IQ

This webinar aimed to explain the impact of COVID-19 crisis on patient behavior in ongoing clinical trials, introduce the application of COV-IQ technology and describe how it…

Read More
Insights

Pandemic Stress Will Affect Clinical Trial Response: What Can Industry Do?

As one might expect, the life changes are a source of stress, and the data supports this assertion. In fact, a recent analysis by Express Scripts also…

Read More
Webinars

The Impact of COVID-19 on Clinical Trial Conduct: The Importance of Considering Patient Stress, Coping and Perceptions

Learn the importance of considering patient psychological traits, expectations, perception of patient relationship with the trial physician and staff, and social structure in efforts to understand the impact of the COVID-19 pandemic on clinical trials.

Read More
Insights

The placebo response in drug development. Part 2: Osteoarthritis

Osteoarthritis (OA) is common musculoskeletal disease with increased incidence and prevalence associated with aging. It affects around 10 % of the population and is 10 times more…

Read More

Understand patient differences in your next clinical trial

Increase your trial’s success rates and bring new therapies to patients faster.

Tell us about your clinical trial below, and our team will be in touch.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.